Metabolex takes $8.6M to treat diabetes
Metabolex, maker of treatments for Type 2 diabetes, has raised $8.6 million in a fifth round of funding to fund trials on its newest product. Based in Hayward, Calif., the company is backed by Alta Partners, Bay City Capital, Birchmere Ventures, Charter Ventures, Merlin Biomed, Novo Ventures, Next Chapter Holdings, VantagePoint Venture Partners, Venrock and Versant Ventures.
Plextronics snaps up $14M for organic lighting, solar cells
Plextronics, a unique company developing organic solar cells and light emitting-diode displays — including television screens so flexible you can bend them — announced today that it’s brought in $14 million in second-round funding. The Pittsburgh company says it will use the money to continue research and spearhead manufacturing operations that will hopefully reach commercial scale.
Organic light emitting-diodes (OLED) include an extremely thin layer of organic compounds that are literally printed onto their surfaces. Because… Continue Reading
Plextronics gets $20.6M more for plastic solar cells, organic RFID tags
Plextronics, a Pittsburgh-based start-up developing organic photovoltaic technology for solar power, said it has raised $20.6 million in a second round of financing.
The round was led by the Solvay Group, a Brussels-based chemical-pharma group, and included Firelake Capital Management, Birchmere Ventures, Draper Triangle Ventures and Newlin Investment Company. Plextronics has raised a total of $37 million in equity capital over the last five years.
The company specializes in “printed electronics,” a field that covers next-generation light… Continue Reading
Metabolex raises $32 million for metabolic disease treatment
Hayward, Calif.’s Metabolex, a biotech company developing treatments for diabetes and related metabolic disorders, said it has raised $32 million in a fourth round of financing.
It was led by MPM BioEquities. New investors AllianceBernstein, Deerfield Management and T. Rowe Price also participated in the round, joined by existing investors Alta Partners, Bay City Capital, Biotech Turnaround Fund, Birchmere Ventures, Johnson & Johnson Development Corporation, KBC Funds, Lombard Odier Darier Hentsch, Pictet Funds (LUX) – Biotecho,… Continue Reading